The learning curve associated with the introduction of the subcutaneous implantable defibrillator

. 2016 Jul ; 18 (7) : 1010-5. [epub] 20150831

Jazyk angličtina Země Velká Británie, Anglie Médium print-electronic

Typ dokumentu časopisecké články, multicentrická studie, pozorovací studie

Perzistentní odkaz   https://www.medvik.cz/link/pmid26324840

AIMS: The subcutaneous implantable cardioverter defibrillator (S-ICD) was introduced to overcome complications related to transvenous leads. Adoption of the S-ICD requires implanters to learn a new implantation technique. The aim of this study was to assess the learning curve for S-ICD implanters with respect to implant-related complications, procedure time, and inappropriate shocks (IASs). METHODS AND RESULTS: In a pooled cohort from two clinical S-ICD databases, the IDE Trial and the EFFORTLESS Registry, complications, IASs at 180 days follow-up and implant procedure duration were assessed. Patients were grouped in quartiles based on experience of the implanter and Kaplan-Meier estimates of complication and IAS rates were calculated. A total of 882 patients implanted in 61 centres by 107 implanters with a median of 4 implants (IQR 1,8) were analysed. There were a total of 59 patients with complications and 48 patients with IAS. The complication rate decreased significantly from 9.8% in Quartile 1 (least experience) to 5.4% in Quartile 4 (most experience) (P = 0.02) and non-significantly for IAS from 7.9 to 4.8% (P = 0.10). Multivariable analysis demonstrated a hazard ratio of 0.78 (P = 0.045) for complications and 1.01 (P = 0.958) for IAS. Dual-zone programming increased with experience of the individual implanter (P < 0.001), which reduced IAS significantly in the multivariable model (HR 0.44, P = 0.01). Procedure time decreased from 75 to 65 min (P < 0.001). The complication rate and procedure time stabilized after Quartile 2 (>13 implants). CONCLUSION: There is a short and significant learning curve associated with physicians adopting the S-ICD. Performance stabilizes after 13 implants.

Zobrazit více v PubMed

Burke MC, Gold MR, Knight BP, Barr CS, Theuns DA, Boersma LV et al. . Safety and efficacy of the totally subcutaneous implantable defibrillator. J Am Coll Cardiol 2015;65:1605–15. PubMed

Kirkfeldt RE, Johansen JB, Nohr EA, Jorgensen OD, Nielsen JC. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J 2014;35:1186–94. PubMed PMC

Gadler F, Valzania C, Linde C. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry. Europace 2014;17:69–77. PubMed

Bardy G, Smith W, Hood M, Crozier I, Melton I, Jordaens L et al. . An entirely subcutaneous implantable cardioverter–defibrillator. N Engl J Med 2010;363:36–44. PubMed

Gold MR, Theuns DA, Knight BP, Sturdivant JL, Sanghera R, Ellenbogen KA et al. . Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study. J Cardiovasc Electrophysiol 2012;23:359–66. PubMed

Hopper A, Jamison M, Lewis W. Learning curves in surgical practice. Postgrad Med J 2007;83:777–9. PubMed PMC

Al-Khatib SM, Lucas FL, Jollis JG, Malenka DJ, Wennberg DE. The relation between patients’ outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating Medicare beneficiaries. J Am Coll Cardiol 2005;46:1536–40. PubMed

Krahn AD, Lee DS, Birnie D, Healey JS, Crystal E, Dorian P et al. . Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD database. Circ Arrhythm Electrophysiol 2011;4:136–42. PubMed

Curtis JP, Luebbert JJ, Wang Y, Rathore SS, Heidenreich PA, Hammill SC et al. . Association of physician certification and outcomes among patients receiving. JAMA 2009;301:1661–70. PubMed PMC

Olde Nordkamp LR, Dabiri Abkenari L, Boersma LV, Maass AH, de Groot JR, van Oostrom AJ et al. . The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort. J Am Coll Cardiol 2012;60:1933–9. PubMed

Weiss R, Knight BP, Gold MR, Leon AR, Herre JM, Hood M et al. . Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation 2013;128:944–53. PubMed

Lambiase PD, Barr C, Theuns DA, Knops RE, Neuzil P, Johansen JB et al. . Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD registry. Eur Heart J 2014;35:1657–65. PubMed PMC

Knops RE, Olde Nordkamp LR, de Groot JR, Wilde AA. Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator. Heart Rhythm 2013;10:1240–3. PubMed

Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP et al. . Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329–38. PubMed

Brisben AJ, Burke MC, Knight BP, Hahn SJ, Herrmann KL, Allavatam V et al. . A new algorithm to reduce inappropriate therapy in the S-ICD system. J Cardiovasc Electrophysiol 2015;26:417–23. PubMed

Kooiman KM, Knops RE, Olde Nordkamp L, Wilde AA, de Groot JR. Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T-wave oversensing can be prevented: implications for management. Heart Rhythm 2014;11:426–34. PubMed

Olde Nordkamp LR, Brouwer TF, Barr C, Theuns DA, Boersma LV, Johansen JB et al. . Inappropriate shocks in the subcutaneous ICD: incidence, predictors and management. Int J Cardiol 2015;195:126–33. PubMed

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace